IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Library CD
Volume 7, 2003 Archive
Six back issues from 2003 on one convenient archive.
Permanent storage and easy retrieval of IJPC articles and formulations.
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

Only $200.00


(Select Format)
Mailed CD
Instant PDF Download

This archive contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 7 No. 1 January/February 2003 Terrorism
Vol. 7 No. 2 March/April 2003 Terrorism
Vol. 7 No. 3 May/June 2003 Diabetes and Wound Care
Vol. 7 No. 4 July/August 2003 After the Women's Health Initiative Trial
Vol. 7 No. 5 September/October 2003 After the Women's Health Initiative Trial
Vol. 7 No. 6 November/December 2003 Compounding for Investigational Studies

Volume 7, 2003 Articles

Volume 7, 2003 Articles
Title (Click for Details) Vol/Issue Page
Compounding for the Effects of Weapons of Mass Destruction Vol. 7 No. 1 10
Diabetes Mellitus: Pathophysiology and Complications Vol. 7 No. 1 17
Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center Vol. 7 No. 1 21
Natural or Bioidentical Hormone Replacement: What makes the Difference? An Interview with Christopher B. Cutter, MD. Vol. 7 No. 1 24
Equine Cushing’s Syndrome Vol. 7 No. 1 27
Establishing and Standardizing Preferred Pharmacy Practices in a Multioffice Infusion Company, Part 2 Vol. 7 No. 1 32
Packaging Choices for Compounded Materials Vol. 7 No. 1 37
Technology Spotlight: Barrier Isolators Vol. 7 No. 1 42
Determining the Availability of a Commercial Drug Vol. 7 No. 1 44
Calculations Vol. 7 No. 1 46
Featured Excipient: Flavor Enhancing Agents Vol. 7 No. 1 48
Basics of Compounding for Terrorist Attacks, Part 1 Vol. 7 No. 1 51
Amoxicillin 125-mg/5-mL and 250-mg/5-mL Suspensions Vol. 7 No. 1 55
Atropine 1-mg Gelatin Troches Vol. 7 No. 1 56
Atropine Sulfate 0.1% for Inhalation Vol. 7 No. 1 57
Atropine Sulfate 0.5-mg/mL Injection Vol. 7 No. 1 58
Gentamicin Sulfate 40-mg/mL Injection Vol. 7 No. 1 59
Levofloxacin 250-mg/5mL Oral Liquid Vol. 7 No. 1 60
Ofloxacin 250-mg/5-mL Oral Liquid Vol. 7 No. 1 60
Potassium Iodide 130-mg Capsules and Potassium Iodide 16-mg/mL Oral Liquid Vol. 7 No. 1 61
Ribavirin 200-mg Capsules Vol. 7 No. 1 62
Sodium Hypochlorite Disinfectant Solutions Vol. 7 No. 1 63
Vancomycin HCl 50-mg/mL Oral Solution Vol. 7 No. 1 64
Stability of Glycopyrrolate Injection at Ambient Temperature and 4°C in Polypropylene Syringes Vol. 7 No. 1 65
Stability of Succinylcholine Chloride Injection at Ambient Temperature and 4 Degree C in Polypropylene Syringes Vol. 7 No. 1 68
Use of Cysteine Hydrochloride Injection to Increase the Solubility of Calcium and Phosphates in FreAmine III-Containing Parenteral Nutrition Solutions Vol. 7 No. 1 71
Wish You Were Here: Deutsche Apotheken Museum (German Museum of Pharmacy) Vol. 7 No. 1 78
Postcription: Future Trends in High Technology Pharmaceutical Compounding Vol. 7 No. 1 80
Book and Literature Reviews Vol. 7 No. 2 84
Legal & Ethical Issues for Pharmacy Websites Vol. 7 No. 2 88
Panel Discussion: Prohormones Vol. 7 No. 2 94
Profile of a Practice: Building a Compounding Pharmacy Practice from the Ground Up: Prescription Compounding Solutions, Medford, Oregon Vol. 7 No. 2 101
Veterinary Transdermal Medications: A to Z Vol. 7 No. 2 106
Autoclaves for the Sterilization of Compounded Parenteral Products Vol. 7 No. 2 114
Barcode System and Computerized Balance Speed Compounding and Enhance Accuracy Vol. 7 No. 2 118
Technology Spotlight: Electronic Balances with Printer and Draft Shield Vol. 7 No. 2 120
Accuracy of Small-Volume Containers Vol. 7 No. 2 124
Autoclave Efficiency Validation Vol. 7 No. 2 126
Calculations Vol. 7 No. 2 128
Basics of Compounding for Terrorist Attacks, Part 2 Vol. 7 No. 2 129
Amoxicillin 250-mg Troches Vol. 7 No. 2 131
Amoxicillin 125-mg Suppositories Vol. 7 No. 2 131
Chloramphenicol 250-mg Capsules Vol. 7 No. 2 131
Chloramphenicol 150-mg/5-mL Suspension Vol. 7 No. 2 131
Cidofovir Suppositories Vol. 7 No. 2 131
Ciprofloxacin Oral Suspension Vol. 7 No. 2 131
Clindamycin HCl 150-mg Capsules Vol. 7 No. 2 132
Clindamycin Phosphate 150-mg Capsules Vol. 7 No. 2 132
Clindamycin 10-mg/mL Oral Suspension Vol. 7 No. 2 132
Doxycycline HCl 100-mg Capsules Vol. 7 No. 2 132
Erythromycin 200-mg Troches Vol. 7 No. 2 132
Erythromycin 250-mg Suppositories Vol. 7 No. 2 132
Penicillin G Potassium 20,000,000-units Injection Vol. 7 No. 2 132
Penicillin G Potassium 1,000,000-unit Injection Vol. 7 No. 2 132
Ribavirin 33-mg/mL Injection Vol. 7 No. 2 132
Rifampin 10-mg/mL Oral Suspension Vol. 7 No. 2 132
Rifampin 150-mg Capsules Vol. 7 No. 2 132
Rifampin 3-mg/mL Intravenous Infusion Vol. 7 No. 2 132
Streptomycin Sulfate 400-mg/mL Injection Vol. 7 No. 2 132
Tetracycline 125-mg/5-mL Syrup Vol. 7 No. 2 132
Tetracycline HCl 20-mg/mL Intravenous Injection Vol. 7 No. 2 132
Tetracycline HCl 250-mg Capsules Vol. 7 No. 2 132
Tetracycline HCl 250-mg Suppositories Vol. 7 No. 2 133
Vancomycin HCl 250-mg Capsules Vol. 7 No. 2 133
Albuterol Sulfate 0.5% Inhalation Solution Vol. 7 No. 2 133
Dimercaptosuccinic Acid 250-mg Capsules Vol. 7 No. 2 133
Sodium Thiosulfate-Sodium Nitrate Solution Vol. 7 No. 2 133
Potassium Iodide Saturated Solution Vol. 7 No. 2 133
Lorazepam 2-mg Gelatin Troches Vol. 7 No. 2 134
Lorazepam 2-mg Polyethlene Glycol Troches Vol. 7 No. 2 134
Oral Liquid Suspending Vehicle Vol. 7 No. 2 134
Diazepam 5-mg/mL Injection Vol. 7 No. 2 135
Dimercaprol 100-mg/mL Injection USP Vol. 7 No. 2 136
Dimercaptopropanesulfonate Sodium 50-mg/mL Injection Vol. 7 No. 2 137
Lorazepam 2-mg Sublingual Tablets Vol. 7 No. 2 138
Mafenide Acetate 85 mg/g Cream USP Vol. 7 No. 2 139
Pralidoxime Chloride 50-mg/mL Injection Vol. 7 No. 2 140
Silver Sulfadiazine 1% Cream Vol. 7 No. 2 141
Sodium Bicarbonate 8.4% Injection USP Vol. 7 No. 2 142
Sodium Nitrite 3% Injection USP Vol. 7 No. 2 143
Sodium Thiosulfate 25% Injection USP Vol. 7 No. 2 144
Featured Excipient: Plasticizers Vol. 7 No. 2 145
Stability of Clindamycin Phosphate in AutoDose Infusion System Bags Vol. 7 No. 2 149
Chemical Stability of Cefazolin Sodium after Reconstituting in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 7 No. 2 152
Quantification of Total Dexamethasone Phosphate Delivery by Iontophoresis Vol. 7 No. 2 155
PostScription: Sterile Product Admixture Preparation Vol. 7 No. 2 160
Book & Literature Reviews Vol. 7 No. 3 164
Five Compounds for Treating Diabetes-Related Conditions Vol. 7 No. 3 170
Ketamine 10 %, Gabapentin 6%, and Nifedipine 2% in PLO Vol. 7 No. 3 171
Sildenafil 25-mg Troches Vol. 7 No. 3 171
Prostaglandin E1/Papaverine HCl/Phentolamine Mesylate Injection Vol. 7 No. 3 171
Misoprostol 0.0024% and Phenytoin 5% Diabetic Ulcer Cream Vol. 7 No. 3 171
Nifedipine 100- mg/mL in PLO Vol. 7 No. 3 171
Case Report: Topical Gel for the Treatment of a Refractory Leg Ulcer Vol. 7 No. 3 176
The History of Pluronic Lecithin Organogel: An Interview With Marty Jones, BSPharm, FACA, FIACP Vol. 7 No. 3 180
ABHR in PLO (Lorazepam, Diphenhydramine HCl, Haloperidol, Metoclopramide HCl) Vol. 7 No. 3 183
Ketoprofen 10% in PLO Vol. 7 No. 3 183
Methimazole 5 mg/0.1 mL in PLO (Vet) Vol. 7 No. 3 183
Wish You Were Here: The Pearson Museum, Springfield, Illinois Vol. 7 No. 3 184
Treating Canine Hepatic Disease Vol. 7 No. 3 188
Incubators Vol. 7 No. 3 193
Further Clarification of HIPAA Regulations Vol. 7 No. 3 195
Software for the Compounding Pharmacist: An Update Vol. 7 No. 3 197
Technology Spotlight: Tube Sealers Vol. 7 No. 3 206
Accuracy of Graduated Cylinders Vol. 7 No. 3 208
Calculations Vol. 7 No. 3 212
Product Containment in the Compounding Laboratory Vol. 7 No. 3 213
Dexamethasone Phosphate 0.05% Ophthalmic Ointment Vol. 7 No. 3 215
Dexamethasone Phosphate 0.1% Topical Cream Vol. 7 No. 3 216
Dimenhydrinate 5-mg/mL Oral Liquid Vol. 7 No. 3 217
Epinephrine Bitartrate 2% Ophthalmic Solution Vol. 7 No. 3 218
Ergotamine Tartrate 2-mg Sublingual Tablets Vol. 7 No. 3 219
Hyoscyamine Sulfate 0.125-mg and Phenobarbital 15-mg/mL Oral Drops Vol. 7 No. 3 220
Methadone HCl 5-mg/mL Injection Vol. 7 No. 3 221
Minocycline 10-mg/mL Oral Liquid Vol. 7 No. 3 222
Phenytoin 6-mg/mL Oral Liquid Vol. 7 No. 3 223
Tetracycline HCl 2.2-mg/mL Topical Solution Vol. 7 No. 3 224
Quality-Control Analytical Methods: Principles of pH Vol. 7 No. 3 225
Standard Operating Procedure: Incubator Temperature Monitoring Vol. 7 No. 3 228
Stability of Amikacin Sulfate in AutoDose Infusion System Bags Vol. 7 No. 3 230
Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets Vol. 7 No. 3 233
PostScription: Too Many Compounders? Vol. 7 No. 3 240
Book Reviews Vol. 7 No. 4 244
Literature Review Vol. 7 No. 4 246
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1 Vol. 7 No. 4 250
Patient Satisfaction with Pharmacist Intervention and Consultation in HRT Vol. 7 No. 4 258
Sensitization Therapy for Warts Vol. 7 No. 4 266
Dinitrochlorobenzene 0.5% to 2.0% in Acetone Vol. 7 No. 4 270
Dinitrochlorobenzene 0.1% to 1 % in Hydrophilic Petrolatum Vol. 7 No. 4 270
Diphenylcyclopropenone 0.01% to 0.1% in Acetone Vol. 7 No. 4 270
Squaric Acid Dibutyl Ester 0.03% to 3.0 in Acetone Vol. 7 No. 4 270
Cantharidine 0.7% Topical Vol. 7 No. 4 270
Fluorouracil 5% Gel Vol. 7 No. 4 270
Podophyllum 25% in Compound Tincture of Benzoin Vol. 7 No. 4 270
Podophyllum 1% and Salicylic Acid 3% in Flexible Collodion Vol. 7 No. 4 270
Salicylic Acid 40% Ointment Vol. 7 No. 4 270
Effectiveness in Oral Rhus toxicodendron Solution for Poison Ivy Prevention Vol. 7 No. 4 272
Rhus Tox Solution 2X Vol. 7 No. 4 272
Rhus Tox Solution 3X Vol. 7 No. 4 272
Rhus Tox Solution 4X Vol. 7 No. 4 272
Rhus Tox Solution 5X Vol. 7 No. 4 272
Rhus Tox Solution 6X Vol. 7 No. 4 272
Rhus Tox Solution 7X Vol. 7 No. 4 272
Rhus Tox Solution 8X Vol. 7 No. 4 272
Rhus Tox Solution 9X Vol. 7 No. 4 272
Rhus Tox Solution 10X Vol. 7 No. 4 272
Rhus Tox Solution 11X Vol. 7 No. 4 272
Rhus Tox Solution 12X Vol. 7 No. 4 272
Rhus Tox 6X/12X Solution Vol. 7 No. 4 272
HIPAA Privacy and Security for Providers: The Basics Vol. 7 No. 4 277
Containment of Hazardous Particulates in the Compounding Pharmacy Vol. 7 No. 4 281
Technology Spotlight: A USP-Grade Water System Vol. 7 No. 4 286
Basics of Compounding for Raynaud's Disease Vol. 7 No. 4 288
Nifedipine in PLO Gel Vol. 7 No. 4 291
Nitroglycerin 0.2% Ointment Vol. 7 No. 4 291
Coenzyme Q10 100-mg-in-Oil Capsules Vol. 7 No. 4 291
Zinc, Magnesium, Caldium and Vitamin D3 Oral Liquid Vol. 7 No. 4 291
How to Handle a Product Recall Vol. 7 No. 4 292
Calculations Vol. 7 No. 4 294
Brompheniramine Maleate 2-mg/5-mL Oral Liquid Vol. 7 No. 4 295
Chlorpheniramine Maleate 10-mg/mL Injection Vol. 7 No. 4 296
Chlorpromazine HCl 30-mg/mL Oral Concentrate Vol. 7 No. 4 297
Desonide 0.05% Otic Liquid Vol. 7 No. 4 298
Hydroxyprogesterone Caproate 250-mg/mL-in-Oil Injection Vol. 7 No. 4 299
Meperidine HCl 100-mg/mL and Atropine Sulfate 0.4-mg/mL Injection Vol. 7 No. 4 300
Meperidine HCl 25-mg/mL and Promethazine HCl 25-mg/mL Injection Vol. 7 No. 4 301
Methocarbamol 400-mg and Aspirin 325-mg Capsules Vol. 7 No. 4 302
Perphenazine 4-mg and Amitriptyline HCl 10-mg capsules Vol. 7 No. 4 303
Triprolidine HCl 1.25-mg/5-mL, Pseudoephedrine HCl 30-mg/5-mL and Codeine Phosphate 10-mg/5-mL Oral Liquid Vol. 7 No. 4 304
Quality-Control Analytical Methods: Viscosity Measurements Vol. 7 No. 4 305
Chemical Stability of Cefuroxime Sodium After Reconstitution in 0.9% Sodium Chloride Injection and Storage in Polypropylene Syringes for Pediatric Use Vol. 7 No. 4 310
Stability of Hydralazine HCl in Both Flavored and Nonflavored Extemporaneous Preparations Vol. 7 No. 4 313
Postcription: Does Your Pharmacy Practice Follow the Pharmacist Code of Ethics? Vol. 7 No. 4 320
Book and Literature Reviews Vol. 7 No. 5 324
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 2 Vol. 7 No. 5 330
Patient Handout - Hormone Replacement Therapy Vol. 7 No. 5 339
The Role of the Pharmacist in Diabetes Care Vol. 7 No. 5 341
Understanding Feline Hyperthyroidism Vol. 7 No. 5 345
Profile of a Practice: Don West, RPh, Lloyd Center Pharmacy, Portland, Oregon Vol. 7 No. 5 350
Vancomycin Pluronic Gel Vol. 7 No. 5 354
Sterile Vancomycin Pluronic Gel for Implantation in the Chest-Wall Cavity to Treat Resistant Pneumococcus Vol. 7 No. 5 354
NDC Numbers: A New Approach Vol. 7 No. 5 358
Application of USP-NF Standards to Pharmacy Compounding Vol. 7 No. 5 361
Technology Spotlight: Respiratory Vial Sealers Vol. 7 No. 5 364
Basics of Compounding for Pediculosis Vol. 7 No. 5 366
Malathion 0.5% Topical Lotion Vol. 7 No. 5 368
Ivermectin 1% Crème Rinse Vol. 7 No. 5 368
Ivermectin 1% Lotion Vol. 7 No. 5 369
Head Lice Repellant Spray Vol. 7 No. 5 369
Standard Operating Procedure: Incubator Cleaning Vol. 7 No. 5 370
Calculations Vol. 7 No. 5 372
Chloramphenicol 1% Topical Ointment Vol. 7 No. 5 373
Guanethidine Monosulfate 10-mg and Hydrochlorothiazide 25-mg Capsules Vol. 7 No. 5 374
Indomethacin 50-mg Suppositories Vol. 7 No. 5 375
Isoniazid 10-mg/mL Oral Solution Vol. 7 No. 5 376
Pentazocine HCl 12.5-mg and Aspirin 325-mg Capsules Vol. 7 No. 5 377
Perphenazine 5-mg/mL Injection Vol. 7 No. 5 378
Phenylbutazone 100-mg Capsules Vol. 7 No. 5 379
Reserpine and Hydrochlorothiazide 0.125-mg/25-mg and 0.125-mg/50-mg Capsules Vol. 7 No. 5 380
Thioridazine HCl 100-mg/mL Concentrated Solution Vol. 7 No. 5 381
Ursodiol 150-mg Capsules Vol. 7 No. 5 382
Quality-Control Analytical Methods: Refractometry Vol. 7 No. 5 383
Stability of Oral Liquid Dosage Forms of Glycopyrrolate Prepared with the Use of Powder Vol. 7 No. 5 386
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Vol. 7 No. 5 389
Educating the Caregiver and Community Pharmacist To Facilitate Provision of Consistent Compounded Medications from the Inpatient to Ambulatory Settings Vol. 7 No. 5 394
Postcriptions: Compounding Paradox: Taught Less and Practiced More Vol. 7 No. 5 399
An Ounce of Prevention: Controlling Hazards in Extemporaneous Compounding Practices Vol. 7 No. 5 401
PreScription: Take Care with Terminology for Altered- and Slow-release Formulations Vol. 7 No. 6 418
Book & Literature Reviews Vol. 7 No. 6 420
Sore Nipples in Breastfeeding Mothers: Causes and Treatments Vol. 7 No. 6 426
Mupirocin 1%, Betamethasone 0.05%, and Miconazole 2% Nipple Ointment Vol. 7 No. 6 430
Mupirocin 0.5%, Betamethasone 0.025%, Nystatin 25,000-U/g and Clotrimazole 0.25% Nipple Ointment Vol. 7 No. 6 430
Mupirocin 0.5%, Betamethasone 0.025%, Nystatin 25,000-U/g and Clotrimazole 2.5% Nipple Ointment Vol. 7 No. 6 430
Compounding for Investigational Studies: The Experience of Ken Hughes, RPh Vol. 7 No. 6 436
Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care Vol. 7 No. 6 441
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Vol. 7 No. 6 449
A Foot in the Door: Marketing Tips Vol. 7 No. 6 454
Technology Spotlight: Automated Prescription-Dispensing Systems Vol. 7 No. 6 458
Basics of Compounding for Dry-Skin Conditions Vol. 7 No. 6 460
Wool Alcohols Ointment Vol. 7 No. 6 462
Water-Absorbing Ointment Vol. 7 No. 6 462
Natural Emollient Oil Vol. 7 No. 6 462
Emulsion Base to be Individualized Vol. 7 No. 6 462
Premixed Oil Phase for Preparing Oil-in-Water (O/W) Emulsions Vol. 7 No. 6 463
O/W Emulsion Vol. 7 No. 6 463
Lotion with Cyclomethicone Vol. 7 No. 6 463
Water-Repelling Lip-Balm Stick Vol. 7 No. 6 463
Lip-Balm Stick (Basic Formula for Individualizing) Vol. 7 No. 6 463
Water-Repelling Lip Ointment Vol. 7 No. 6 463
Lip Ointment (Basic Ointment for Individualizing) Vol. 7 No. 6 463
Storage of Bulk Chemicals and Finished Preparations Vol. 7 No. 6 464
Calculations Vol. 7 No. 6 466
Bacitracin 500-U/g Ophthalmic Ointment Vol. 7 No. 6 467
Chloramphenicol 0.5% Ophthalmic Solution Vol. 7 No. 6 468
Clotrimazole 500-mg Vaginal Suppositories Vol. 7 No. 6 469
Ergoloid Mesylate 1-mg/mL Oral Liquid Vol. 7 No. 6 470
Meclocycline Sulfosalicylate 1% Cream Vol. 7 No. 6 471
Methadone HCl 2.5-mg Capsules Vol. 7 No. 6 472
Perphenazine 2.5-mg/5-mL Syrup Vol. 7 No. 6 473
Sulfasalazine 250-mg/5-mL Oral Liquid Vol. 7 No. 6 474
Tramadol HCl 100-mg Capsules Vol. 7 No. 6 475
Triprolidine HCl 2.5-mg Capsules Vol. 7 No. 6 476
Quality-Control Analytical Methods: Specific-Gravity Determinations of Liquids and Semisolids Vol. 7 No. 6 477
Pharmacokinetics of Sumatriptan 25-mg Oral Tablet Versus 25-mg Extemporaneous Suppository in Healthy Volunteers Vol. 7 No. 6 481
Stability of Two Concentrations of Tiagabine in an Extemporaneously Compounded Suspension Vol. 7 No. 6 485
Patient Interest in Pharmacist-Provided Menopause and Hormone Replacement Therapy Consultations Vol. 7 No. 6 490
PostScription: Changing Pharmacy Regulations Could Affect US Compounders Vol. 7 No. 6 495